Results 181 to 190 of about 44,865 (239)

Prevalence and prognostic impact of BRAF V600E mutation and CDKN2A deletion in pediatric high-grade glioma. [PDF]

Front Oncol
Karim S, Mosaab A, Taha H, Naguib I, Refaat A, Maher E, Zaghloul MS, El-Beltagy M, Hafez H, Kamal M, Salem S, Kieran MW, El-Hemaly A, El-Haddad A.   +13 more
europepmc   +1 more source

Rosai-Dorfman disease disguised as BRAF V600E-positive histiocytosis - a diagnostic pitfall. [PDF]

Blood Res
Ravindran A, Goyal G, Morlote D, Mackinnon AC.   +3 more
europepmc   +1 more source

BRAF V600E Mutation in Ganglioglioma: Impact on Epileptogenicity and Implications for Surgical Strategy. [PDF]

Eur J Neurol
Tomschik M, Horner E, Lang A, Mayer F, Czech T, Kasprian G, Pataraia E, Azizi AA, Feucht M, Rössler K, Haberler C, Dorfer C.   +11 more
europepmc   +1 more source

Clinical outcomes of dabrafenib plus trametinib in locally advanced or metastatic BRAF V600E-mutant papillary thyroid cancer. [PDF]

Am J Cancer Res
Chen YH, Chou CK, Chi SY, Chang YH, Wang PW, Chan YC.   +5 more
europepmc   +1 more source

A single-center retrospective study of dabrafenib plus trametinib combination therapy in patients with BRAF V600E-positive thyroid cancer. [PDF]

Int J Clin Oncol
Ando T, Oya Y, Tomiie Y, Ogawa K, Kuki T, Tanabe Y, Kato H, Imaizumi K, Hibi Y, Kawada K.   +9 more
europepmc   +1 more source

Questioning the Role of BRAF V600E as a Prognostic Indicator in Papillary Thyroid Carcinoma. [PDF]

Ann Surg Oncol
Javid M.
europepmc   +1 more source

BRAF V600E Expression in c-Kit+ Interstitial Cells of Cajal Drives Gastrointestinal Stromal Tumor Formation in Mice. [PDF]

Cancer Res Commun
Tomassoni-Ardori F, Reilly KM, Barrick C, Koogle R, Edmondson EF, Yanpallewar S, Saur D, Widemann BC, Glod JW, Tessarollo L.   +9 more
europepmc   +1 more source

Successful treatment of osimertinib-resistant EGFR-mutant NSCLC with acquired BRAF V600E mutation using triple combination therapy: a case report with pathological confirmation. [PDF]

World J Surg Oncol
Lin M, Chen X, Lin F, Yang Y.
europepmc   +1 more source

Clinicopathological Features and Prognosis of Unresectable Colorectal Cancer With the <i>BRAF V600E</i> Mutation. [PDF]

Cancer Diagn Progn
Ono Y, Numata K, Iguchi K, Uchiyama M, Asari M, Rino Y, Saito A, Shiozawa M.   +7 more
europepmc   +1 more source

Rare MSI-H hepatoid adenocarcinoma of the colon with BRAF V600E mutation achieving long-term disease-free survival after adjuvant envafolimab: a case report. [PDF]

Front Immunol
Fan S, Meng Q, Zhao Z, Niu W.
europepmc   +1 more source